Related Experiment Videos
Cardiovascular defects in rat embryos cultured on serum from rats chronically exposed to phenytoin
Insights
Phenytoin exposure in pregnant rats led to significant cardiovascular defects in their offspring. These defects, including hemorrhaging and edema, occurred without altering key serum markers like glucose or phosphate.
Area of Science:
- Developmental biology
- Toxicology
- Teratology
Background:
- Phenytoin is an anticonvulsant medication with known teratogenic potential.
- Chronic exposure effects on embryonic development are not fully understood.
- Maternal serum composition changes during chronic drug exposure may impact fetal development.
Purpose of the Study:
- To investigate the impact of maternal chronic phenytoin exposure on embryonic cardiovascular development.
- To identify potential serum-based mechanisms mediating phenytoin's teratogenic effects.
- To assess the role of serum protein alterations in phenytoin-induced embryopathy.
Main Methods:
- Culturing of headfold-stage rat embryos in vitro.
- Exposure of pregnant rats to phenytoin from conception to 11 months.
- Analysis of serum composition (glucose, phosphate, osmolality, protein, hemopexin) in exposed and control rats.
- Morphological assessment of cultured embryos for cardiovascular abnormalities.
Main Results:
- Serum from phenytoin-exposed rats induced cardiovascular defects in approximately 50% of cultured embryos, compared to 12% in controls.
- Observed abnormalities included intraembryonic hemorrhaging, pericardial edema, and absent yolk sac circulation.
- Phenytoin exposure reduced serum protein concentration and hemopexin levels but did not significantly alter glucose, phosphate, or osmolality.
Conclusions:
- Chronic maternal phenytoin exposure is associated with a high incidence of cardiovascular malformations in developing rat embryos.
- Reduced serum protein concentration, potentially involving hemopexin, is a consequence of phenytoin exposure but not the direct cause of cardiovascular defects.
- Further research is needed to elucidate the precise mechanisms linking phenytoin exposure to specific cardiovascular teratogenicity.
Abstract:
Headfold-stage rat embryos were cultured for 48 hours on serum from rats chronically exposed to phenytoin for periods as long as from conception until 11 months of age. Serum from phenytoin-exposed rats caused approximately 50% of the cultured rat embryos to develop cardiovascular defects as compared to 12% for controls. These morphological abnormalities included hemorrhaging of blood vessels within the embryo, pericardial edema, and absence of yolk sac circulation. Neither serum glucose nor phosphate levels nor serum osmolality were appreciably affected by phenytoin treatment. However, serum protein concentration was reduced in rats exposed to phenytoin as compared to controls. An absence of the serum protein hemopexin was associated with the reduction in serum protein levels but did not appear to be responsible for the observed cardiovascular defects.